Publication

Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus

Related publications (53)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus

Graph Chatbot

Chat with Graph Search

Atomic-Scale Description of Interfaces between Antigen and Aluminum-Based Adjuvants Used in Vaccines by Dynamic Nuclear Polarization (DNP) Enhanced NMR Spectroscopy

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity

Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity

Nucleic acids presenting polymer nanomaterials as vaccine adjuvants

Antibody‐mediated crosslinking of gut bacteria hinders the spread of antibiotic resistance

Development of a nano-adjuvant cancer vaccine and its evaluation for melanoma in combination with radiotherapy

Structure-based immunogen design - leading the way to the new age of precision vaccines

Genetic determinants of healthy human immune variance: from humoral response to microbiome diversity

Evaluation of oxidation-sensitive polymersomes as vaccine nanocarriers to enhance humoral responses against arenavirus envelope glycoproteins

Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses